Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.
CRISPR-based gene editing shows promise in treating rare form of blindness
About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness,